Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Encapsulation study of citalopram and risperidone into nanostructured silica SBA-15 for in vitro release evaluation (2017)

  • Authors:
  • USP affiliated authors: MATOS, JIVALDO DO ROSARIO - IQ
  • USP Schools: IQ
  • DOI: 10.1007/s10973-016-5995-4
  • Subjects: MATERIAIS NANOESTRUTURADOS; SOLVENTE; TERMOGRAVIMETRIA
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1007/s10973-016-5995-4 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Versões disponíveis em Acesso Aberto do: 10.1007/s10973-016-5995-4 (Fonte: Unpaywall API)

    Título do periódico: Journal of Thermal Analysis and Calorimetry

    ISSN: 1388-6150,1588-2926



      Não possui versão em Acesso aberto
    Informações sobre o Citescore
  • Título: Journal of Thermal Analysis and Calorimetry

    ISSN: 1388-6150

    Citescore - 2017: 2.1

    SJR - 2017: 0.587

    SNIP - 2017: 1.073


  • How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      TANAKA, Magali Naomi; SANTOS, Solange Teixeira Soares; GOUVEIA, Marize Aparecida; et al. Encapsulation study of citalopram and risperidone into nanostructured silica SBA-15 for in vitro release evaluation. Journal of Thermal Analysis and Calorimetry, Dordrecht, v. 127, n. 2, p. 1725-1732, 2017. Disponível em: < http://dx.doi.org/10.1007/s10973-016-5995-4 > DOI: 10.1007/s10973-016-5995-4.
    • APA

      Tanaka, M. N., Santos, S. T. S., Gouveia, M. A., Santos Filho, M. dos, Cosentino, I. C., Barbosa Neto, J. B., et al. (2017). Encapsulation study of citalopram and risperidone into nanostructured silica SBA-15 for in vitro release evaluation. Journal of Thermal Analysis and Calorimetry, 127( 2), 1725-1732. doi:10.1007/s10973-016-5995-4
    • NLM

      Tanaka MN, Santos STS, Gouveia MA, Santos Filho M dos, Cosentino IC, Barbosa Neto JB, Tufik S, Matos J do R, Mercuri LP. Encapsulation study of citalopram and risperidone into nanostructured silica SBA-15 for in vitro release evaluation [Internet]. Journal of Thermal Analysis and Calorimetry. 2017 ; 127( 2): 1725-1732.Available from: http://dx.doi.org/10.1007/s10973-016-5995-4
    • Vancouver

      Tanaka MN, Santos STS, Gouveia MA, Santos Filho M dos, Cosentino IC, Barbosa Neto JB, Tufik S, Matos J do R, Mercuri LP. Encapsulation study of citalopram and risperidone into nanostructured silica SBA-15 for in vitro release evaluation [Internet]. Journal of Thermal Analysis and Calorimetry. 2017 ; 127( 2): 1725-1732.Available from: http://dx.doi.org/10.1007/s10973-016-5995-4

    Referências citadas na obra
    Kresge CT, Leonowics ME, Roth WJ, Vartuli JC, Beck JS. Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism. Nature. 1992;359:710–2.
    Stein A, Melde BJ, Schroden RC. Hybrid inorganic-organic mesoporous silicates-nanoscopic reactors coming of age. Adv Mater. 2000;12:1403–19.
    Van Speybroeck M, Barillaro V, Thi TD, Mellaerts R, Martens J, Humbeeck JV, Vermant J, Annaert P, Mooter GVD, Augustijns PJ. Ordered mesoporous silica material SBA-15: a broad-spectrum formulation platform for poorly soluble drugs. J Pharm Sci. 2009;98:2648–58.
    Matos JR, Mercuri LP, Kruk M, Jaroniec M. Toward the synthesis of extra-large-pore MCM-41 analogues. Chem Mater. 2001;13:1726–31.
    Cassiers K, Linssen T, Mathieu M, Benjelloun M, Schrijnemakers K, Van der Voort P, Cool P, Vansant EF. A detailed study of thermal, hydrothermal, and mechanical stabilities of a wide range of surfactant assembled mesoporous silicas. Chem Mater. 2002;14:2317–24.
    Carvalho LV, Ruiz RDC, Scaramuzzi K, Marengo EB, Matos JR, Tambourgi DV, Fantini MCA. Sant’Anna OA. Immunological parameters related to the adjuvant effect of the ordered mesoporous silica SBA-15. Vaccine. 2010;28:7829–36.
    Mercuri LP, Carvalho L, Lima F, Quayle C, Fantini M, Tanaka G, Cabrera W, Furtado M, Tambourgi D, Matos JR, Sant’Anna OA. Ordered mesoporous silica SBA-15: a new effective adjuvant to induce antibody response. Small. 2006;2:254–6.
    Ehlert N, Badar M, Christel A, Lohmeier SJ, Luessenhop T, Stieve M, Lenarz T, Mueller PP, Behrens P. Mesoporous silica coatings for controlled release of the antibiotic ciprofloxacin from implants. J Mater Chem. 2011;21:752–60.
    Ni M, Xu QQ, Yin JZ. Preparation of controlled release nanodrug ibuprofen supported on mesoporous silica using supercritical carbon dioxide. J Mater Res. 2012;27:2902–10.
    Chowdhury MA. The Controlled release of drugs and bioactive compounds from mesoporous silica nanoparticles. Curr Drug Deliv. 2016;13:839–56.
    Karimi M, Mirshekari H, Aliakbari M, Sahandi-Zangabad P, Hamblin MR. Smart mesoporous silica nanoparticles for controlled-release drug delivery. Nanotechnol Rev. 2016;5:195–207.
    Pires SA, Mussel WN, Yoshida MI. Solid-state characterization and pharmaceutical compatibility between citalopram and excipients using thermal and non-thermal techniques. J Therm Anal Calorim. 2016;. doi: 10.1007/s10973-016-5769-z .
    Madaan V, Bestha DP, Kolli V, Jauhari S, Burket RC. Clinical utility of the risperidone formulations in the management of schizophrenia. Neuropsychiatr Dis Treat. 2011;7:611–20.
    Abdouss M, Asadi E, Azodi-Deilami S, Beik-mohammadi N, Aslanzadeh SA. Development and characterization of molecularly imprinted polymers for controlled release of citalopram. J Mater Sci Mater Med. 2011;22:2273–81.
    Badshah A, Subhan F, Rauf K, Bukhari NI, Shah K, Khan S, Ahmed Z, Khan I. Development of controlled-release matrix tablet of risperidone: influence of Methocel®- and Ethocel®-based novel polymeric blend on in vitro drug release and bioavailability. AAPS PharmSciTech. 2011;12:525–33.
    Siafaka PI, Barmpalexis P, Lazaridou M, Papageorgiou GZ, Koutris E, Karavas E, Kostoglou M, Bikiaris DN. Controlled release formulations of risperidone antipsychotic drug in novel aliphatic polyester carriers: data analysis and modelling. Eur J Pharm Biopharm. 2015;94:473–84.
    Nokhodchi A, Raja S, Patel P, Asare-Addo K. The role of oral controlled release matrix tablets in drug delivery systems. Bioimpacts. 2012;2:175–87.
    Wen H, Park K, editors. Oral controlled release formulation design and drug delivery: theory to practice. New Jersey: Wiley; 2010. p. 1.
    Menegola J, Steppe M, Schapoval EE. Dissolution test for citalopram in tablets and comparison of in vitro dissolution profiles. Eur J Pharm Biopharm. 2007;67:524–30.
    USP 31: United States Pharmacopeial Convention. The United States pharmacopeia: the national formulary (USP XXXI-NF26). Rockville: The United States Pharmacopeial Convention, 2008, p. 813–4.
    Kumar MS, Smith AA, Vasagam GA, Muthu AK, Manavalan R. Development of analytical method for risperidone by UV spectrophotometry. Inter J Pharma Sci Res. 2010;1:122–6.
    García-Martinez J, Li K, editors. Mesoporous zeolites: preparation, characterization and applications. Weinheim: Wiley; 2015. p. 358.
    Lopez T, Ortiz-Islas E, Lopez M, Flores J, Corona T. Occlusion of Interferon® and Copaxone® on SBA-15 silica reservoirs for their use in the treatment of demyelization diseases. J Nanomater Mol Nanotechnol. 2013;2:1–6.
    Barrêto Gomes AP, Souza FS, Macêdo RO. Thermal and dissolution kinetics of ampicillin drug and capsules. J Therm Anal Calorim. 2003;72:545–8.
    Patel PV, Patel H, Panchal SS, Mehta T. Self micro-emulsifying drug delivery system of tacrolimus: formulation, in vitro evaluation and stability studies. Int J Pharm Investig. 2013;3:95–104.
    Ha ES, Baek I, Yoo JW, Jung Y, Kim MS. Improving dissolution and oral bioavailability of pranlukast hemihydrate by particle surface modification with surfactants and homogenization. Drug Des Devel Ther. 2015;9:3257–66.
    Bouchoucha M, Côté MF, Gaudreault RC, Fortin MA, Kleitz F. Size-controlled functionalized mesoporous silica nanoparticles for tunable drug release and enhanced anti-tumoral activity. Chem Mater. 2016;28:4243–58.
    Brühwiler D. Postsynthetic functionalization of mesoporous silica. Nanoscale. 2010;2:887–92.
    Yang P, Gai S, Lin J. Functionalized mesoporous silica materials for controlled drug delivery. Chem Soc Rev. 2012;41:3679–98.